Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and ...

Immunotherapy is leading the charge in the advancement of cancer treatment. In addition to increased life expectancy, it ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...